These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 1705405)
1. Stopping the biologic clock for globin gene switching. Perrine SP; Faller DV; Swerdlow P; Miller BA; Bank A; Sytkowski AJ; Reczek J; Rudolph AM; Kan YW Ann N Y Acad Sci; 1990; 612():134-40. PubMed ID: 1705405 [TBL] [Abstract][Full Text] [Related]
2. Butyric acid modulates developmental globin gene switching in man and sheep. Perrine SP; Swerdlow P; Faller DV; Qin G; Rudolph AM; Reczek J; Kan YW Adv Exp Med Biol; 1989; 271():177-83. PubMed ID: 2484761 [TBL] [Abstract][Full Text] [Related]
3. Butyrate infusions in the ovine fetus delay the biologic clock for globin gene switching. Perrine SP; Rudolph A; Faller DV; Roman C; Cohen RA; Chen SJ; Kan YW Proc Natl Acad Sci U S A; 1988 Nov; 85(22):8540-2. PubMed ID: 2460870 [TBL] [Abstract][Full Text] [Related]
4. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders. Perrine SP; Ginder GD; Faller DV; Dover GH; Ikuta T; Witkowska HE; Cai SP; Vichinsky EP; Olivieri NF N Engl J Med; 1993 Jan; 328(2):81-6. PubMed ID: 7677966 [TBL] [Abstract][Full Text] [Related]
5. Hemoglobin switching in unicellular erythroid culture of sibling erythroid burst-forming units: kit ligand induces a dose-dependent fetal hemoglobin reactivation potentiated by sodium butyrate. Gabbianelli M; Testa U; Massa A; Pelosi E; Sposi NM; Riccioni R; Luchetti L; Peschle C Blood; 2000 Jun; 95(11):3555-61. PubMed ID: 10828043 [TBL] [Abstract][Full Text] [Related]
6. Effects of butyrate and glucocorticoids on gamma- to beta-globin gene switching in somatic cell hybrids. Zitnik G; Peterson K; Stamatoyannopoulos G; Papayannopoulou T Mol Cell Biol; 1995 Feb; 15(2):790-5. PubMed ID: 7529873 [TBL] [Abstract][Full Text] [Related]
7. Delay in the fetal globin switch in infants of diabetic mothers. Perrine SP; Greene MF; Faller DV N Engl J Med; 1985 Feb; 312(6):334-8. PubMed ID: 2578609 [TBL] [Abstract][Full Text] [Related]
8. Butyrate-induced reactivation of the fetal globin genes: a molecular treatment for the beta-hemoglobinopathies. Perrine SP; Faller DV Experientia; 1993 Feb; 49(2):133-7. PubMed ID: 7680003 [TBL] [Abstract][Full Text] [Related]
9. Butyrate derivatives. New agents for stimulating fetal globin production in the beta-globin disorders. Perrine SP; Olivieri NF; Faller DV; Vichinsky EP; Dover GJ; Ginder GD Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):67-71. PubMed ID: 7508690 [TBL] [Abstract][Full Text] [Related]
11. Sodium butyrate enhances fetal globin gene expression in erythroid progenitors of patients with Hb SS and beta thalassemia. Perrine SP; Miller BA; Faller DV; Cohen RA; Vichinsky EP; Hurst D; Lubin BH; Papayannopoulou T Blood; 1989 Jul; 74(1):454-9. PubMed ID: 2473801 [TBL] [Abstract][Full Text] [Related]
12. MB-02 cells undergo fetal to adult globin gene switching in response to erythropoietin. Perrine SP; Miller BA; Morgan DA Biochem Biophys Res Commun; 1989 Oct; 164(2):857-62. PubMed ID: 2479377 [TBL] [Abstract][Full Text] [Related]
13. Alterations in protein-DNA interactions in the gamma-globin gene promoter in response to butyrate therapy. Ikuta T; Kan YW; Swerdlow PS; Faller DV; Perrine SP Blood; 1998 Oct; 92(8):2924-33. PubMed ID: 9763579 [TBL] [Abstract][Full Text] [Related]
14. Stimulation of fetal hemoglobin production by short chain fatty acids. Liakopoulou E; Blau CA; Li Q; Josephson B; Wolf JA; Fournarakis B; Raisys V; Dover G; Papayannopoulou T; Stamatoyannopoulos G Blood; 1995 Oct; 86(8):3227-35. PubMed ID: 7579419 [TBL] [Abstract][Full Text] [Related]
15. Enhanced fetal hemoglobin production by phenylacetate and 4-phenylbutyrate in erythroid precursors derived from normal donors and patients with sickle cell anemia and beta-thalassemia. Fibach E; Prasanna P; Rodgers GP; Samid D Blood; 1993 Oct; 82(7):2203-9. PubMed ID: 7691251 [TBL] [Abstract][Full Text] [Related]
16. Isobutyramide, an orally bioavailable butyrate analogue, stimulates fetal globin gene expression in vitro and in vivo. Perrine SP; Dover GH; Daftari P; Walsh CT; Jin Y; Mays A; Faller DV Br J Haematol; 1994 Nov; 88(3):555-61. PubMed ID: 7529533 [TBL] [Abstract][Full Text] [Related]
17. Butyrate in the treatment of sickle cell disease and beta-thalassemia. Faller DV; Perrine SP Curr Opin Hematol; 1995 Mar; 2(2):109-17. PubMed ID: 9371980 [TBL] [Abstract][Full Text] [Related]
18. Control of the simian fetal hemoglobin switch at the progenitor cell level. Alter BP; Jackson BT; Lipton JM; Piasecki GJ; Jackson PL; Kudisch M; Nathan DG J Clin Invest; 1981 Feb; 67(2):458-66. PubMed ID: 6161945 [TBL] [Abstract][Full Text] [Related]
19. Cellular and molecular effects of a pulse butyrate regimen and new inducers of globin gene expression and hematopoiesis. Ikuta T; Atweh G; Boosalis V; White GL; Da Fonseca S; Boosalis M; Faller DV; Perrine SP Ann N Y Acad Sci; 1998 Jun; 850():87-99. PubMed ID: 9668531 [TBL] [Abstract][Full Text] [Related]
20. Role of intergenic human gamma-delta-globin sequences in human hemoglobin switching and reactivation of fetal hemoglobin in adult erythroid cells. Bank A; O'Neill D; Lopez R; Pulte D; Ward M; Mantha S; Richardson C Ann N Y Acad Sci; 2005; 1054():48-54. PubMed ID: 16339651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]